Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OTUD7B | Q6GQQ9 | 3/20 | 0.48 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 2/20 | 0.30 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HTR7 | P34969 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27244841 | 0.91 | OTUD7B (0.50) | OTUD7BPTK2BBRD4CREBBPAHR | |
| SCHEMBL30890677 | 0.84 | OTUD7B (0.43) | OTUD7B | |
| SCHEMBL30890510 | 0.81 | OTUD7B (0.40) | OTUD7B | |
| Hydrochloric Acid SCHEMBL30890637 | 0.79 | OTUD7B (0.39) | OTUD7B | |
| Hydrochloric Acid SCHEMBL27244867 | 0.79 | OTUD7B (0.39) | OTUD7B | |
| SCHEMBL27244811 | 0.79 | OTUD7B (0.44) | OTUD7BPTK2BBRD4CREBBP | |
| SCHEMBL27244852 | 0.79 | OTUD7B (0.44) | OTUD7BPTK2BBRD4CREBBP | |
| SCHEMBL27244813 | 0.78 | HTR2B (0.32) | BRD4CREBBPHTR2B | |
| SCHEMBL27244782 | 0.77 | SIRT2 (0.30) | — | |
| SCHEMBL27245066 | 0.77 | OTUD7B (0.43) | OTUD7B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199647-A1 | ANTI-VIRAL COMPOUNDS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2024-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199647-A1 | ANTI-VIRAL COMPOUNDS | EIF2AK2, ZC3HAV1, HAVCR2 | OTUD7B 2426/4885PTK2B 4687/4885ELANE 246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.